USA Rare Earth (USAR) is in acute distress. Shares dropped 32.4 percent over the past month, crushing the S&P 500's 3.1 percent decline, and closed Nov. 16, 2026, at a 52-week low—77 percent below the yearly high.
The damage is structural, not cyclical. Third-quarter sales plummeted to $3 million from $5.82 million in Q2, a 48 percent collapse driven by China's export restrictions on heavy rare earths and samarium metal. Worse: the company sold at catastrophic losses. Gross margin hit minus 662.3 percent in Q3, down from minus 27.2 percent in Q2. That is not operational stress—that is the company paying customers to take product.
Operating losses are accelerating. For the four quarters ending Sept. 30, 2026, USAR posted a $250 million operating loss versus $39.3 million a year earlier. Free cash flow deteriorated to negative $463 million from negative $38.8 million. The company has burned through capital faster than it has generated any.
Management blamed elevated raw material costs and certain capitalized costs now expensed. The company projects margin recovery from its Stillwater magnet plant and LCM metals business as they scale. It also expects relief from repricing older LCM contracts in H1 2027. These are promises, not facts.
USAR's one operational bright spot: the November close of its merger with Serra Verde, a heavy rare earth producer. Management expects Serra Verde to contribute at least 325 tons of rare earth oxides to Q4 sales. That contribution arrives in a quarter when supply-chain shocks have already proved the company's model fragile.
The balance sheet remains a cushion. USAR reported $1.09 billion in cash and short-term investments against $309 million in debt as of Sept. 30, 2026. That runway matters—the company can operate at a loss for several quarters—but cash does not fix broken unit economics.
Historical precedent is unforgiving. During the 2025 U.S. tariff shock, USAR shares fell 69 percent peak to trough while the S&P 500 dropped 18.8 percent. The stock's volatility in a market downturn is 3.7 times the broad index. That beta makes USAR a core-portfolio risk in any recession.
The investment case hinges on three assumptions: (1) the magnet business scales to meaningful volume and positive margins; (2) China's export curbs ease, normalizing raw material availability; (3) Serra Verde integration adds stable, profitable revenue. None has been proven. Until one is, USAR remains a speculative turnaround, not a rare-earth play.
